[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f-t7yiQFGxeqYEQnx839e37o9Tq46zbiW8shVKfMY4-o":8,"$f86R1ZCv9vuFjlZV338JMcVnNMvyh17gE6YxqYohWHXM":55,"$fxLZu4Xku-u5_BCZlV922oPBmomY-NkOrNmV6oLd6LDU":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},51840,869732,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//qvhCCTIvcNBh6P1V3cjuUDfxcVOObxse.png","杨丰名","浙江大学医学院附属第二医院","肿瘤科","主治医师",41,0,"肺癌骨转移与TP53基因突变：用药安全全解读","","https://ystcdn.venuertc.com/venue/AI/8580876b-d9bb-41be-857c-ba5ecf31ffcb.jpg","\u003Cdiv class=\"lcg_material_main_wrap\">\n  \u003Ch1 id=\"material_title\" class=\"lcg_material_title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺癌骨转移与TP53基因突变：用药安全全解读\u003C/h1>\n  \u003Cdiv class=\"lcg_material_section\" style=\"background: linear-gradient(90deg, #f6f9fb 0%, #eaeef7 100%); margin-bottom:24px; border-radius: 12px; padding:32px 30px 24px 30px;\">\n    \u003Cp style=\"font-size:18px; margin:0 0 8px 0; color:#325b7d; font-weight:bold;\">\n      日常生活中，化疗药物、靶向制剂、止痛药和辅助药都常常用在医学治疗环节。尤其涉及晚期患者时，这些药品的联合使用更是需要特别留意。今天这份指南，我们梳理出7大核心细节，教你在实际用药时如何避开风险、发挥最大疗效，做到用得安全、用得明白。\u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"lcg_material_section\" style=\"margin-bottom: 42px;\">\n    \u003Ch2 class=\"lcg_material_subtitle\" style=\"background: linear-gradient(90deg, rgb(224, 234, 239) 0%, rgb(241, 247, 250) 100%); padding: 22px 0px 24px 32px; border-radius: 8px 8px 0px 0px; font-weight: 700; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      01 药品主要成分和剂型有哪些？🧪\n    \u003C/h2>\n    \u003Cdiv style=\"padding: 16px 32px; background: #f8fafc; border-radius: 0 0 8px 8px;\">\n      \u003Cp style=\"margin: 0 0 10px 0;\">与肺癌骨转移治疗紧密相关的核心药品包括：\u003Cspan style=\"color:#426687;font-weight:500;\">铂类化疗药物（如顺铂、卡铂、奥沙利铂）、靶向药（常见如贝伐珠单抗、厄洛替尼）、骨转移专用药（比如唑来膦酸、地诺单抗）\u003C/span>，以及口服止痛药（阿片类、对乙酰氨基酚等）、升白细胞药（如重组人粒细胞刺激因子）等。\u003C/p>\n      \u003Cul style=\"margin-left: 18px; line-height: 1.7;\">\n        \u003Cli>化疗药物多数为注射剂型；部分靶向药是片剂或胶囊。\u003C/li>\n        \u003Cli>骨转移用药如唑来膦酸为静脉滴注，地诺单抗为皮下注射。\u003C/li>\n        \u003Cli>止痛药常见有片剂、缓释片和口服液。\u003C/li>\n        \u003Cli>升白细胞药主要为注射剂。\u003C/li>\n      \u003C/ul>\n      \u003Cp style=\"margin-top:10px;\">正确做法：\u003Cspan style=\"color:#29798e;\">严格对照药品说明书选择剂型，不随意更换剂型或品牌，尤其避免注射制剂私自口服等错误用法。\u003C/span>\u003C/p>\n      \u003Cp style=\"margin-top:12px;\">案例分析：有位72岁男性患者，在含铂双药化疗时，配合唑来膦酸静脉滴注，效果良好，无明显不良反应。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lcg_material_section\" style=\"margin-bottom: 42px;\">\n    \u003Ch2 class=\"lcg_material_subtitle\" style=\"background: linear-gradient(90deg, rgb(237, 242, 251) 0%, rgb(237, 244, 254) 100%); padding: 22px 0px 24px 32px; border-radius: 8px 8px 0px 0px; font-weight: 700; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      02 药品作用机制简析 ⚙️\n    \u003C/h2>\n    \u003Cdiv style=\"padding: 16px 32px; background: #fcfcfe; border-radius: 0 0 8px 8px;\">\n      \u003Cul style=\"margin-left: 20px; line-height: 1.7;\">\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">铂类化疗：\u003C/span>通过与癌细胞DNA结合，抑制DNA链复制，引发细胞死亡（Olaussen, K.A., et al., 2006）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">靶向药：\u003C/span>如EGFR/VEGF通路相关药，直接抑制肿瘤细胞信号传导，使细胞凋亡或停止生长（Jackman, D.M., et al., 2006）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">唑来膦酸：\u003C/span>抑制骨吸收，减少骨相关并发症发生，通过抑制破骨细胞起效（Saad, F., et al., 2002）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">升白细胞药：\u003C/span>刺激骨髓造血，增加外周白细胞（Smith, T.J., et al., 2015）。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp style=\"margin:10px 0 0 0;\">需要注意：\u003Cspan style=\"color:#a0522d;\">部分药物机制相互补充，但也可能加重部分副作用，如骨髓抑制风险。\u003C/span>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lcg_material_section\" style=\"margin-bottom: 42px;\">\n    \u003Ch2 class=\"lcg_material_subtitle\" style=\"background: linear-gradient(90deg, rgb(225, 237, 230) 0%, rgb(225, 238, 236) 100%); padding: 22px 0px 24px 32px; border-radius: 8px 8px 0px 0px; font-weight: 700; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      03 正确的用药时间与服药方法 ⏰\n    \u003C/h2>\n    \u003Cdiv style=\"padding: 16px 32px; background: #f5faf6; border-radius: 0 0 8px 8px;\">\n      \u003Cul style=\"margin-left: 24px; line-height:1.7;\">\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">化疗药：\u003C/span>通常按疗程在医院、日间病房静脉注射。\u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">靶向药：\u003C/span>每日同一时间口服，最好选择清晨或早餐后30分钟服用。\u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">骨转移药物：\u003C/span>唑来膦酸需稀释后缓慢滴注，地诺单抗皮下给药，每次注射完成后注意补钙。\u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">止痛药：\u003C/span>需遵医嘱按时服用，不可随意增减剂量、不自行停药。\u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">辅助药物：\u003C/span>如升白细胞药，通常在化疗周期后次日予注射。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：\u003Cspan style=\"color:#29798e;\">服药时配足量温水，不与深色果汁、浓茶、牛奶等一起吞服；胶囊药品直接吞咽，缓释制剂不可掰碎。\u003C/span>\u003C/p>\n      \u003Cp>自问一句：所有药品的最佳服药时间我是否明确？服药行为和说明书是否一致？\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lcg_material_section\" style=\"margin-bottom: 42px;\">\n    \u003Ch2 class=\"lcg_material_subtitle\" style=\"background: linear-gradient(90deg, rgb(255, 251, 225) 0%, rgb(250, 243, 231) 100%); padding: 22px 0px 24px 32px; border-radius: 8px 8px 0px 0px; font-weight: 700; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      04 主要不良反应及针对性处理 🙋‍♂️\n    \u003C/h2>\n    \u003Cdiv style=\"padding: 16px 32px; background: #fffcee; border-radius: 0 0 8px 8px;\">\n      \u003Cul style=\"margin-left: 24px; line-height:1.7;\">\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">铂类化疗：\u003C/span>可能出现白细胞减少、消化道反应（参考Olaussen KA, et al., 2006）。出现高热、乏力等需及时就医，必要时注射升白细胞药物。\u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">靶向药：\u003C/span>常见有皮疹、口腔黏膜反应等。\u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">唑来膦酸：\u003C/span>偶见低钙血症、肾功能影响，配合补充钙剂与维生素D。\u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">止痛药：\u003C/span>有困倦、消化不良、偶有便秘现象；缓解方法为多饮水、适度活动。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv style=\"margin-left: 0.5em;\">\n        \u003Cstrong>出现不良反应怎么办？\u003C/strong>\n        \u003Cul style=\"margin-left: 18px;\">\n          \u003Cli>升白细胞药物可用于化疗后血象下降者，但必须在医师指导下应用。\u003C/li>\n          \u003Cli>新起皮疹、口腔疼痛时暂缓药物，及时复诊。\u003C/li>\n          \u003Cli>口服唑来膦酸/地诺单抗期间若头晕乏力，需检测电解质、肾功能等。\u003C/li>\n        \u003C/ul>\n      \u003C/div>\n      \u003Cp style=\"margin-top:8px;\">案例补充：有老年患者联合用药后出现牙龈疼痛，按医嘱暂停口服药物，同时加强口腔护理，一周内症状明显缓解。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lcg_material_section\" style=\"margin-bottom: 42px;\">\n    \u003Ch2 class=\"lcg_material_subtitle\" style=\"background: linear-gradient(90deg, rgb(251, 238, 246) 0%, rgb(254, 250, 255) 100%); padding: 22px 0px 24px 32px; border-radius: 8px 8px 0px 0px; font-weight: 700; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      05 药物相互作用与用药禁忌🛑\n    \u003C/h2>\n    \u003Cdiv style=\"padding: 16px 32px; background: #f8f2f8; border-radius: 0 0 8px 8px;\">\n      \u003Cul style=\"margin-left: 24px; line-height:1.7;\">\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">化疗药+升白细胞药：\u003C/span>联用需密切监测血象，但不可擅自提前或过量。\u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">唑来膦酸/地诺单抗：\u003C/span>与利尿剂同服时注意低钙血风险，肾功能减退者禁用唑来膦酸。\u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">靶向药物：\u003C/span>部分药物与PPI（如奥美拉唑）同服可显著影响吸收度，需分时段服药。\u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">止痛药：\u003C/span>阿片类与酒精并用增加中枢抑制风险，必须严格避免。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：\u003Cspan style=\"color:#b45f06;\">配药及用药过程中主动告知医生所有药品名称，包括保健品，避免用药冲突。\u003C/span>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lcg_material_section\" style=\"margin-bottom: 42px;\">\n    \u003Ch2 class=\"lcg_material_subtitle\" style=\"background: linear-gradient(90deg, rgb(221, 227, 253) 0%, rgb(234, 243, 251) 100%); padding: 22px 0px 24px 32px; border-radius: 8px 8px 0px 0px; font-weight: 700; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      06 特殊人群（老年、肾肝功能不全）用药提示🧓\n    \u003C/h2>\n    \u003Cdiv style=\"padding: 16px 32px; background: #f1f6fa; border-radius: 0 0 8px 8px;\">\n      \u003Cul style=\"margin-left: 24px; line-height:1.7;\">\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">老年患者：\u003C/span> 新陈代谢慢，所有药品首剂量和调整频率需缓慢递增。注意监测肾功能。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">肝肾功能受损者：\u003C/span>部分化疗药、唑来膦酸、地诺单抗等需要对应减量或避免。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">孕妇、哺乳妇女：\u003C/span>化疗药、靶向药、唑来膦酸、升白细胞药等均属禁用品种。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>特别提醒：\u003Cspan style=\"color:#6756b8;\">如发现用药后精神状态显著改变，或出现尿量异常、皮肤黄染，应立即就医复查。\u003C/span>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lcg_material_section\" style=\"margin-bottom: 42px;\">\n    \u003Ch2 class=\"lcg_material_subtitle\" style=\"background: linear-gradient(90deg, rgb(242, 243, 232) 0%, rgb(246, 242, 237) 100%); padding: 22px 0px 24px 32px; border-radius: 8px 8px 0px 0px; font-weight: 700; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      07 药品储存、有效期及漏服处理📦\n    \u003C/h2>\n    \u003Cdiv style=\"padding: 16px 32px; background: #fcfcf3; border-radius: 0 0 8px 8px;\">\n      \u003Cul style=\"margin-left: 24px; line-height:1.7;\">\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">大部分口服药：\u003C/span>应放置于干燥、避光、低于25℃的环境中。避免受潮，远离儿童。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">注射剂：\u003C/span>需冷藏（2-8℃），使用时恢复至室温，不可反复冻融。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">过期药品：\u003C/span>不自行服用，统一回收或交由药房处理。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:500;\">漏服处理：\u003C/span>一旦发现非时间临近下次服药，及时补服一次；若即将到下次服药，则不需补服，以防过量。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：\u003Cspan style=\"color:#919949;\">最好使用分药盒、闹钟提醒、记录表等辅助措施，降低漏服概率，提高药物依从性。\u003C/span>\u003C/p>\n      \u003Cp>实际案例：不少患者通过设置手机闹铃显著减少漏服事件。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lcg_material_section\" style=\"margin-bottom: 10px;\">\n    \u003Ch2 class=\"lcg_material_subtitle\" style=\"background: linear-gradient(90deg, rgb(224, 229, 239) 0%, rgb(241, 242, 255) 100%); padding: 22px 0px 24px 32px; border-radius: 8px 8px 0px 0px; font-weight: 700; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">\n      08 总结与用药安全要点🔖\n    \u003C/h2>\n    \u003Cdiv style=\"padding: 16px 32px; background: #f4f6f9; border-radius: 0 0 8px 8px;\">\n      \u003Cul style=\"margin-left: 24px;\">\n        \u003Cli>\n          铂类化疗、靶向药、骨转移药、辅助用药等需联合方案、分时段、科学使用，每种药物有其专属服药细节和风险提示。\n        \u003C/li>\n        \u003Cli>\n          超过一半患者不良反应可被及时识别与处理，关键在于主动报告，及时调整。\n        \u003C/li>\n        \u003Cli>\n          家庭用药储存、分装与科学补服措施不可忽视，每一个细节都关乎疗效和安全。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp style=\"margin-top:8px; font-weight:500;\">最后：记住信息有疑问及时咨询专业医生/药师，不随意尝试新药或擅自停药，是任何阶段用药最安全的选择。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lcg_material_refwrap\" style=\"margin-top:40px; padding: 12px 30px 18px 30px; border-radius:8px; background: #e0e5ec; color:#225d5d;\">\n    \u003Ch3 style=\"margin: 1.2em 0px 0.6em; font-size: 18px; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n    \u003Col style=\"margin-left: 30px; font-size: 16px;\">\n      \u003Cli>Olaussen, K. A., Dunant, A., Fouret, P., Brambilla, E., André, F., Haddad, V., ... & Soria, J. C. (2006). \u003Ci>DNA repair by ERCC1 in non–small-cell lung cancer and cisplatin-based adjuvant chemotherapy\u003C/i>. New England Journal of Medicine, 355(10), 983-991.\u003C/li>\n      \u003Cli>Jackman, D. M., Yeap, B. Y., Sequist, L. V., Lindeman, N., Holmes, A. J., Joshi, V. A., ... & Johnson, B. E. (2006). \u003Ci>Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non–small cell lung cancer patients treated with gefitinib or erlotinib\u003C/i>. Clinical Cancer Research, 12(13), 3908-3914.\u003C/li>\n      \u003Cli>Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., ... & Anaissie, E. (2002). \u003Ci>A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma\u003C/i>. Journal of the National Cancer Institute, 94(19), 1458-1468.\u003C/li>\n      \u003Cli>Smith, T. J., Bohlke, K., Lyman, G. H., Carson, K. R., Crawford, J., Cross, S. J., ... & Weir, A. B. (2015). \u003Ci>Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline update\u003C/i>. Journal of Clinical Oncology, 33(28), 3199-3212.\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.lcg_material_main_wrap {\n  max-width: 806px;\n  margin: 32px auto;\n  box-shadow: 0 4px 24px #dbdee6;\n  background: #fff;\n  font-family: 'Segoe UI', 'Microsoft YaHei', Arial, sans-serif;\n  font-size: 18px;\n  color: #2b3539;\n  border-radius: 16px;\n  overflow:hidden;\n}\n.lcg_material_title {\n  font-size: 2.2em;\n  font-weight: bold;\n  text-align:center;\n  color:#125885;\n  letter-spacing: 1px;\n  margin: 0 0 30px 0;\n  background: linear-gradient(90deg,#cce8fa 0%, #f3fafd 100%);\n  padding:40px 0 30px 0;\n  border-radius: 16px 16px 0 0;\n}\n.lcg_material_subtitle {\n  font-size: 1.35em;\n  color: #384876;\n  margin:0;\n}\n.lcg_material_section {\n  margin-bottom: 32px;\n}\n.lcg_material_refwrap {\n  font-size: 0.97em;\n  line-height: 1.7;\n}\n@media (max-width: 900px) {\n  .lcg_material_main_wrap {max-width:97vw;}\n}\n\u003C/style>\n","\u003Cdiv class=\"lcg_material_main_wrap\">\n  \u003Ch1 id=\"material_title\" class=\"lcg_material_title\" style=\"col",509,"2025-07-24 09:42:20","肺癌骨转移, TP53基因突变, 化疗药物, 不良反应, 用药安全","本文深入解读肺癌骨转移与TP53基因突变下的用药安全要点，明确药物分类、作用机制、不良反应及相互作用，帮助患者更安全有效地用药。","2025-07-27 10:20:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]